Abstract
ObjectivesTo evaluate radiographic progression of structural joint damage over 2 years in patients with rheumatoid arthritis from baricitinib clinical trials who were disease-modifying antirheumatic drug (DMARD)–naïve or had an inadequate...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have